SAN FRANCISCO (Reuters) – Reuters asked a U.S. judge on Thursday to unseal documents filed in court regarding potential risks associated with Propecia, Merck & Co’s (MRK.N) popular baldness drug.
The motion was filed in federal court in Brooklyn, New York, after a Reuters article on Wednesday revealed accusations that Merck did not fully disclose on Propecia’s label the incidence and duration of sexual dysfunction in men who took Propecia in clinical trials. Those allegations are contained in court filings that had been intended to be filed under seal.
Court let Merck hide secrets about a drug’s risks
Federal District Judge Brian Cogan has allowed Merck to keep secret internal company documents in litigation brought by Propecia users against the company. A faulty redaction allowed Reuters to view some of the details in a plaintiff’s brief, but the underlying Merck documents cited in that brief are still sealed. Those are the documents the Reuters motion seeks…
Source news reuters.com, click here to read the full news.
